In a mouse model of ACLF, treatment with IL‐22 therapy, provided in the form of IL‐22Fc (two IL‐22 molecules linked to an immunoglobulin constant region), promoted liver repair and reduced bacterial infection.25 Here, IL22 is linked to bacterial infectious disease.